[PETDAG] QoQ TTM Result on 30-Jun-2012 [#2]

Stock
[PETDAG] PETRONAS DAGANGAN BHD
Announcement Date
16-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- 34.79%
YoY- 190.54%
Quarter Report
Latest QR
Upcoming QR
PETDAG's Result
PETDAG's Financial Summary
View:
Show?
TTM Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 31/12/11 CAGR
Revenue 30,281,180 29,514,963 28,679,717 21,189,776 13,705,510 6,852,755 6,382,665 247.72%
PBT 1,152,456 1,165,173 1,254,103 913,609 679,372 339,686 315,541 182.03%
Tax -317,698 -321,903 -340,735 -244,827 -183,604 -91,802 -85,768 185.23%
NP 834,758 843,270 913,368 668,782 495,768 247,884 229,773 180.83%
-
NP to SH 827,732 836,846 906,559 663,748 492,422 246,211 228,456 180.23%
-
Tax Rate 27.57% 27.63% 27.17% 26.80% 27.03% 27.03% 27.18% -
Total Cost 29,446,422 28,671,693 27,766,349 20,520,994 13,209,742 6,604,871 6,152,892 250.15%
-
Net Worth 5,046,746 480,831,736 4,808,317 4,957,335 0 4,917,597 4,783,232 4.38%
Dividend
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 31/12/11 CAGR
Div 695,417 1,043,126 695,417 521,563 347,708 173,854 595,972 13.14%
Div Payout % 84.01% 124.65% 76.71% 78.58% 70.61% 70.61% 260.87% -
Equity
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 31/12/11 CAGR
Net Worth 5,046,746 480,831,736 4,808,317 4,957,335 0 4,917,597 4,783,232 4.38%
NOSH 993,454 993,454 993,454 993,454 993,454 993,454 994,435 -0.07%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 31/12/11 CAGR
NP Margin 2.76% 2.86% 3.18% 3.16% 3.62% 3.62% 3.60% -
ROE 16.40% 0.17% 18.85% 13.39% 0.00% 5.01% 4.78% -
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 31/12/11 CAGR
RPS 3,048.07 2,970.94 2,886.87 2,132.94 1,379.58 689.79 641.84 247.99%
EPS 83.32 84.24 91.25 66.81 49.57 24.78 22.97 180.48%
DPS 70.00 105.00 70.00 52.50 35.00 17.50 60.00 13.13%
NAPS 5.08 484.00 4.84 4.99 0.00 4.95 4.81 4.46%
Adjusted Per Share Value based on latest NOSH - 993,454
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 31/12/11 CAGR
RPS 3,048.07 2,970.94 2,886.87 2,132.94 1,379.58 689.79 642.47 247.72%
EPS 83.32 84.24 91.25 66.81 49.57 24.78 23.00 180.19%
DPS 70.00 105.00 70.00 52.50 35.00 17.50 59.99 13.14%
NAPS 5.08 484.00 4.84 4.99 0.00 4.95 4.8147 4.38%
Price Multiplier on Financial Quarter End Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 31/12/11 CAGR
Date 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/12/11 -
Price 23.10 23.50 22.50 21.10 18.94 17.80 17.80 -
P/RPS 0.76 0.79 0.78 0.99 1.37 2.58 2.77 -64.48%
P/EPS 27.72 27.90 24.66 31.58 38.21 71.82 77.48 -56.07%
EY 3.61 3.58 4.06 3.17 2.62 1.39 1.29 127.89%
DY 3.03 4.47 3.11 2.49 1.85 0.98 3.37 -8.16%
P/NAPS 4.55 0.05 4.65 4.23 0.00 3.60 3.70 18.00%
Price Multiplier on Announcement Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 31/12/11 CAGR
Date 23/05/13 - - - - 21/05/12 24/02/12 -
Price 25.24 0.00 0.00 0.00 0.00 19.48 18.00 -
P/RPS 0.83 0.00 0.00 0.00 0.00 2.82 2.80 -62.21%
P/EPS 30.29 0.00 0.00 0.00 0.00 78.60 78.35 -53.26%
EY 3.30 0.00 0.00 0.00 0.00 1.27 1.28 113.41%
DY 2.77 0.00 0.00 0.00 0.00 0.90 3.33 -13.70%
P/NAPS 4.97 0.00 0.00 0.00 0.00 3.94 3.74 25.55%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment